Late Outcomes of Konno-Rastan and Modified Konno for Left Ventricular Outflow Tract Obstruction

Elaine M Griffeth1, Joseph A Dearani1, Kenneth R Hassler1

  • 1Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota.

PubMed

Insights

Long-term follow-up of Konno-Rastan and modified Konno procedures reveals recurrent left ventricular outflow tract (LVOT) obstruction over time. Despite preserved heart function, late survival remains poor in young patients after these complex surgeries.

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Cardiology
  • Congenital Heart Disease

Background:

  • Early outcomes of Konno-Rastan and modified Konno procedures are established.
  • Long-term clinical and echocardiographic outcomes of these complex left ventricular outflow tract (LVOT) obstruction surgeries remain largely undetermined.

Purpose of the Study:

  • To examine the long-term clinical and echocardiographic outcomes of patients who underwent Konno-Rastan and modified Konno procedures.
  • To identify risk factors associated with mortality in this patient population.

Main Methods:

  • Retrospective review of 92 patients undergoing Konno-Rastan or modified Konno for complex LVOT obstruction (1980-2021).
  • Exclusion of the Ross-Konno procedure due to limited ventriculotomy.
  • Analysis of clinical data, echocardiographic parameters, reoperation rates, and overall survival.

Main Results:

  • Median follow-up was 12 years. Aortic valve/LVOT mean gradient increased from 13 mm Hg at 1 year to 25 mm Hg at 10 years.
  • Freedom from reoperation at 10 years was 58.4% for Konno-Rastan and 41.7% for modified Konno.
  • Overall survival at 15 years was 65.5%. Risk factors for mortality included older age, NYHA class III/IV, longer cardiopulmonary bypass time, and multilevel LVOT obstruction.

Conclusions:

  • Recurrent LVOT obstruction occurs over time following Konno-Rastan and modified Konno procedures.
  • Despite preserved left ventricular systolic function, late overall survival is poor in this young patient population.
  • These findings highlight the need for long-term monitoring and potential reinterventions.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
18
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
16
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
13